Paul Collini

Summary

Affiliation: University of Sheffield
Country: UK

Publications

  1. doi request reprint Clostridium Difficile Infection in Patients with HIV/AIDS
    Paul J Collini
    Department of Infection and Immunity, The University of Sheffield Medical School and Sheffield Teaching Hospitals, Room LU108, L Floor, Beech Hill Road, Sheffield, S10 2RX, UK
    Curr HIV/AIDS Rep 10:273-82. 2013
  2. doi request reprint Clostridium difficile infection in HIV-seropositive individuals and transplant recipients
    Paul J Collini
    Department of Infection and Immunity, University of Sheffield Medical School and Sheffield Teaching Hospitals, Beech Hill Rd, Sheffield S10 2RX, UK
    J Infect 64:131-47. 2012
  3. doi request reprint Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort
    Paul Collini
    School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, United Kingdom
    Clin Infect Dis 48:988-91. 2009

Detail Information

Publications3

  1. doi request reprint Clostridium Difficile Infection in Patients with HIV/AIDS
    Paul J Collini
    Department of Infection and Immunity, The University of Sheffield Medical School and Sheffield Teaching Hospitals, Room LU108, L Floor, Beech Hill Road, Sheffield, S10 2RX, UK
    Curr HIV/AIDS Rep 10:273-82. 2013
    ..Here we review the evidence for these observations and the relevance of recent advances in the diagnosis and management of CDI for the HIV clinician. ..
  2. doi request reprint Clostridium difficile infection in HIV-seropositive individuals and transplant recipients
    Paul J Collini
    Department of Infection and Immunity, University of Sheffield Medical School and Sheffield Teaching Hospitals, Beech Hill Rd, Sheffield S10 2RX, UK
    J Infect 64:131-47. 2012
    ..However all these conditions are characterised by high levels of antibiotic use and prolonged hospital stay, both powerful drivers of CDI risk...
  3. doi request reprint Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort
    Paul Collini
    School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, United Kingdom
    Clin Infect Dis 48:988-91. 2009
    ..However, two-thirds of patients who experienced immunological failure did not switch treatment, and 31% of all patients were lost to follow-up...